THU-263 - Pharmacokinetics and safety of glecaprevir/pibrentasvir in adults with chronic genotype 1–6 hepatitis C virus infection and compensated cirrhosis: an integrated analysis

Autor: Gane, E., Poordad, F., Valdes, J., Lin, C.-W., Liu, W., Asatryan, A., Wang, S., Stedman, C., Greenbloom, S., Nguyen, T., Elkhashab, M., Wörns, M.-A., Tran, A., Mulkay, J.-P., Yu, Y., Porcalla, A., Mensa, F.
Zdroj: In Journal of Hepatology 2017 66(1) Supplement:S306-S306
Databáze: ScienceDirect
Externí odkaz: